InvestorsHub Logo
Followers 10
Posts 380
Boards Moderated 0
Alias Born 09/27/2018

Re: MEAD II post# 8720

Saturday, 11/03/2018 7:00:58 PM

Saturday, November 03, 2018 7:00:58 PM

Post# of 64083
Yeah at least $0.10 a share. The company has too much research behind it. A good team of physicians. A clinical trial under its belt. This is truly rock bottom pricing from here on out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News